News

News

  • Job openings at CEPI
  • CEPI seeks a vendor for new IT platform
  • Chikungunya Workshop
  • CEPI vaccine R&D pipeline and cost tracking survey
  • Board member nominations now closed

Job openings at CEPI

CEPI is looking for

  • A Policy Manager located in the CEO’s office in Oslo, Norway. If you are interested in joining the CEPI team and have the appropriate qualifications for this role, please check out the job description below.
    Application deadline: November 20, 2017
    Questions regarding this position may be directed to Astrid Helgeland.
  • Experienced Programme and Contract Managers located in the London, UK office. If you are interested in joining the CEPI team in London and have appropriate qualifications for either of these roles, please check out the job decriptions below.
    Questions regarding this position may be directed to Glenn Foster.

Please send your application to CEPI.

The CEPI team is growing rapidly and we will be announcing a number of executive appointments in coming weeks and months.

Job description Policy Manager

PDF FORMAT - 411KB

Download

Job description Contract Manager

PDF FORMAT - 110KB

Download

Job description Programme Manager

PDF FORMAT - 97KB

Download

CEPI seeks a vendor for new IT platform

CEPI has decided to procure a complete IT platform with corresponding IT services. A tender is published that set high demands to security and to global delivery.

Chikungunya Workshop

The Department of Biotechnology, India and CEPI are organising a workshop “Chikungunya vaccines- challenges, opportunities and possibilities” on 5th and 6th February 2018 in Delhi, India. This workshop will bring together international delegates for two days of intense dialogue on ideas, data, challenges and opportunities related to Chikungunya vaccine development. Invited speakers will lead a programme with oral presentations, lively panel discussions and stimulating poster sessions.

CEPI vaccine R&D pipeline and cost tracking survey

CEPI is inviting you to participate in a survey that is mapping vaccine research and development pipelines and associated costs for emerging infectious diseases.

The survey is open until 10 November 2017.

To achieve its strategic objectives, and to make efficient use of its financial resources, CEPI needs to draw on a variety of vaccine candidates and leverage diversity of product development partners. CEPI is currently building up a comprehensive knowledge base on available vaccine candidates and their current status, in order to serve vaccine preparedness needs against non-commercial epidemic disease threats.

Our request

Through this survey, you are asked to:

  • Report the current status of development of vaccine candidates against non-commercial epidemic disease threats.
  • Clarify current sources of funding, development costs incurred and future funding needs for bringing the vaccines through phase II and potentially phase III in response to potential disease outbreaks.
  • Specify main drivers of R&D costs and technical success to date and identify potential drivers of future costs and technical risks for bringing your vaccine candidates through late stages of clinical development.

Diseases in scope

  • Diseases that are of main interest to CEPI include those listed by the WHO Blueprint as priority diseases: Crimean Congo haemorrhagic fever, Lassa fever, MERS-CoV, Severe acute respiratory syndrome, Nipah, Rift Valley Fever, Chikungunya, Zika, Severe fever with thrombocytopaenia syndrome, Ebola, Marburg. (For more details, see here).
  • Other diseases that have epidemic potential and which are not included in the WHO priority list.

Contact: Pipeline@cepi.net

Please submit your completed survey file via our webform or email.

CEPI vaccine R&D pipeline and cost tracking survey

Please note that you will have to click "enable content" before you can edit the text.

ZIP FORMAT - 58KB

Download

Board member nominations now closed

CEPI recently announced that it is looking for visionary leaders to serve on its new permanent Board and help guide the coalition through its next phase of growth, maximising the positive impact that CEPI can make in the years ahead.

Applications closed on October 1, 2017. We thank everybody who submitted nominations, and will follow up soon.

Advert

PDF FORMAT - 50KB

Download

CEPI Animation

Below you can see the prize winning animation developed for the CEPI launch campaign in January 2017. The #OutsmartEpidemics campaign was crowned winner of the Best of Use of Digital and STEM Campaign categories in the Chartered Institute of Public Relations (CIPR) Excellence Awards 2017.

Press releases

CfP to reduce time to develop vaccines against epidemics

Coalition aims to provide a global defence against emerging infectious diseases by developing platforms for rapid development and manufacturing of vaccines.

Media release, 5 September 2017, Oslo – Coalition for Epidemic Preparedness Innovations

Read more here.

 

Norway strengthens its commitment to CEPI

CEPI welcomes global leadership shown by government of Norway

Media release, Oslo 08 July 2017 – Coalition for Epidemic Preparedness Innovations

Read more here.

 

CEPI permanent CEO

Dr Richard Hatchett offered position as permanent CEO of CEPI

Media release, Oslo 28 Feb 2017 – Coalition for Epidemic Preparedness Innovations

Read more here.

 

CEPI officially launched

Global partnership launched to prevent epidemics with new vaccines

Media release, Davos 18 Jan 2017 – Coalition for Epidemic Preparedness Innovations

Read more here.

CEPI Newsletter

CEPI Newsletter 1 November 2017

PDF FORMAT - 182KB

Download

CEPI Newsletter 13 October 2017

PDF FORMAT - 362KB

Download

CEPI Newsletter 30 September 2017

PDF FORMAT - 186KB

Download

CEPI Newsletter 15 September

PDF FORMAT - 86KB

Download

CEPI Newsletter 1 September 2017

PDF FORMAT - 344KB

Download

CEPI Newsletter 14 July 2017

PDF FORMAT - 121KB

Download

CEPI Newsletter January - June 2017

PDF FORMAT - 964KB

Download

CEPI Newsletters 2016

PDF FORMAT - 1KB

Download